| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/09/2000 | EP0977538A1 Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use |
| 02/09/2000 | EP0618808B1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 02/09/2000 | EP0608313B1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 02/09/2000 | CN1244132A Device for local administration of solid and semisolid pharmaceutical for mulations, sustained-release pharmaceutical formulations for parenteral administration and method of preparation |
| 02/09/2000 | CN1244130A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 02/09/2000 | CN1244129A Useof dimeticone as transport and carrier system and/or drug delevery system |
| 02/09/2000 | CN1244127A Freeze-dried composition of bone morphogenetic protein human MP52 |
| 02/09/2000 | CN1244121A Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 02/09/2000 | CN1244119A Rapidly releasing and taste-masking pharmaceutical dosage form |
| 02/09/2000 | CN1243827A Preparation of heterocyclic amide derivative with specific physical status |
| 02/09/2000 | CN1243702A Method for adding activated medicinal compounds into foundamental materials |
| 02/09/2000 | CN1049114C Method for prepn. of slowly-released medicaments preparation |
| 02/08/2000 | US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development |
| 02/08/2000 | US6022874 Piperazine based cytofectins |
| 02/08/2000 | US6022866 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 02/08/2000 | US6022860 Immobilized and activity-stabilized complexes of LHRH antagonists and processes for their preparation |
| 02/08/2000 | US6022854 Platelet specific therapeutic compound and method of treating |
| 02/08/2000 | US6022852 Comprising cyclosporin a, tocopherol, polyethylene glycol 1000 succinate and, optionally, an emulsifier, with the exception of vegetable oil or fat; administering by mouth; kidney disorders; topical; psoriasis, wound healing agents |
| 02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 02/08/2000 | US6022565 Extract of jewelweed (impatiens species such as impatiens capensis, impatiens biflora, impatiens balsamea, and impatiens pallida), extract of plantain leaf, and aqueous colloidal dispersion of subdivided whole oat grains; poison ivy |
| 02/08/2000 | US6022562 Medicinal and/or nutritional microcapsules for oral administration |
| 02/08/2000 | US6022561 Galactolipid material extracted from cereals selected from the group consisting of wheat, rye, and oats, containing at least about 50% by weight of digalactosyldiacylglycerol; drug delivery, cosmetics |
| 02/08/2000 | US6022559 Aqueous dispersion of dehydration-resistant vesicles |
| 02/08/2000 | US6022558 Transdermal preparations of oxicams |
| 02/08/2000 | US6022544 Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
| 02/08/2000 | US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| 02/08/2000 | CA2271571C Improved phase separation-microencapsulated pharmaceutical compositions useful for alleviating dental disease |
| 02/08/2000 | CA2234364C Compositions for inhibiting platelet aggregation |
| 02/08/2000 | CA2004597C Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo-[4,5-c]quinoline-4-amine |
| 02/08/2000 | CA2004064C Supported drugs with increased dissolution rate, and a process for theirpreparation |
| 02/03/2000 | WO2000005316A1 Coating of solid surfaces with activated polyhydroxypolymers |
| 02/03/2000 | WO2000005307A1 Coating and excipient agent for oral or dermal dosage forms |
| 02/03/2000 | WO2000005276A1 A process for the preparation of aqueous dispersions of latex particles having a heterogeneous morphology, the latex particles obtainable with the process, the dispersions and redispersible powders, as well as the use thereof |
| 02/03/2000 | WO2000005275A1 Redispersible powder and its aqueous dispersion, preparation process and use |
| 02/03/2000 | WO2000005274A1 Method for producing powder-shaped cross-linked polymerizates |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |
| 02/03/2000 | WO2000005257A1 Pectic substance as a growth factor stabilizer |
| 02/03/2000 | WO2000004939A1 Dental pin |
| 02/03/2000 | WO2000004937A1 Flat flexible materials |
| 02/03/2000 | WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 02/03/2000 | WO2000004925A1 Slow release formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004924A1 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 02/03/2000 | WO2000004913A1 Fsh and fsh variant formulations, products and methods |
| 02/03/2000 | WO2000004907A1 An antilipemic formulation |
| 02/03/2000 | WO2000004906A1 Non-aqueous anthelmintic composition |
| 02/03/2000 | WO2000004902A1 Stabilized carvedilol injection solution |
| 02/03/2000 | WO2000004899A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | WO2000004897A1 Bioimplant formulation |
| 02/03/2000 | WO2000004891A2 Anti-ulcer composition |
| 02/03/2000 | WO2000004886A1 Formulations for the transdermal administration of fenoldopam |
| 02/03/2000 | WO2000004882A1 Formulations of anionic polysaccharides |
| 02/03/2000 | WO2000004881A1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 02/03/2000 | WO2000004877A1 Suppository formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004875A2 Preparation of aqueous clear solution dosage forms with bile acids |
| 02/03/2000 | WO2000004862A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 02/03/2000 | WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999063932A3 Multibinding agents that modulate the 5-ht transporter |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1999060120A3 Soluble t cell receptor |
| 02/03/2000 | WO1999060119A3 Multivalent t cell receptor complexes |
| 02/03/2000 | WO1999058571A3 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 02/03/2000 | WO1999056772A3 Hepatitis vaccine |
| 02/03/2000 | DE19834821A1 Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil |
| 02/03/2000 | DE19834820A1 Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil |
| 02/03/2000 | DE19834819A1 Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil |
| 02/03/2000 | DE19834506A1 Transmucosales therapeutisches System zur Anwendung von Sildenafil Transmucosal therapeutic system for the administration of sildenafil |
| 02/03/2000 | DE19833062A1 Redispergierbares Pulver und dessen wäßrige Dispersion, Verfahren zur Herstellung sowie Verwendung Redispersible powder and the aqueous dispersion A process for producing and using |
| 02/03/2000 | DE19833061A1 Verfahren zur Herstellung wäßriger Dispersionen von Latexteilchen mit heterogener Morphologie, die mit dem Verfahren erhältlichen Latexteilchen, die Dispersionen und redispergierbaren Pulver sowie deren Verwendung A process for preparing aqueous dispersions of latex particles with heterogeneous morphology, the latex particles obtainable by the process, the dispersions and redispersible powders, as well as their use |
| 02/03/2000 | CA2338345A1 Encapsulation of water soluble peptides |
| 02/03/2000 | CA2338307A1 Pectic substance as a growth factor stabilizer |
| 02/03/2000 | CA2338269A1 Coating of solid surfaces with activated polyhydroxypolymers |
| 02/03/2000 | CA2337893A1 A process for the preparation of aqueous dispersions of latex particles having a heterogeneous morphology, the latex particles obtainable with the process, the dispersions and redispersible powders, as well as the use thereof |
| 02/03/2000 | CA2337349A1 Ophthalmic compositions for treating ocular hypertension |
| 02/03/2000 | CA2335340A1 Fsh and fsh variant formulations, products and methods |
| 02/02/2000 | EP0976407A1 Antiseptic composition |
| 02/02/2000 | EP0976406A1 Transdermal composition containing glibenclamide and benzyl alcohol |
| 02/02/2000 | EP0976405A1 Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition |
| 02/02/2000 | EP0976400A1 Preventive or remedy for kidney diseases |
| 02/02/2000 | EP0976394A1 New injectable formulations |
| 02/02/2000 | EP0976382A1 Cosmetic or dermopharmaceutical patch |
| 02/02/2000 | EP0975791A1 Marine bacterial strain of the genus vibrio, water-soluble polysaccharides produced by said strain and their uses |
| 02/02/2000 | EP0975790A1 New method for isolating polysaccharides |
| 02/02/2000 | EP0975762A1 Type-1 ribosome-inactivating protein |
| 02/02/2000 | EP0975680A1 Interactive system for substance presentation and elimination |
| 02/02/2000 | EP0975674A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 02/02/2000 | EP0975670A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy |
| 02/02/2000 | EP0975370A2 Composition and method for enhancing transport across biological membranes |
| 02/02/2000 | EP0975369A1 Polyethylene glycol-interferon alpha conjugates for therapy of infection |
| 02/02/2000 | EP0975368A1 Sustained drug delivery and compositions useful therefor |
| 02/02/2000 | EP0975367A1 Improved delivery of drugs to mucosal surfaces |
| 02/02/2000 | EP0975357A1 Transdermal delivery system |
| 02/02/2000 | EP0975348A1 Stabilized tibolone compositions |
| 02/02/2000 | EP0975340A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/02/2000 | EP0975339A1 Pharmaceutical composition for the programmed release of dexfenfluramine |
| 02/02/2000 | EP0975335A1 Stable pharmaceutical administration forms of peptides, proteins and nucleic acids |
| 02/02/2000 | EP0975334A1 Biodegradable microparticles for the sustained delivery of therapeutic drugs |